Copyright
©The Author(s) 2025.
World J Gastroenterol. Apr 28, 2025; 31(16): 104920
Published online Apr 28, 2025. doi: 10.3748/wjg.v31.i16.104920
Published online Apr 28, 2025. doi: 10.3748/wjg.v31.i16.104920
Figure 1 N-methyl-N’-nitro-N-nitrosoguanidine-induced malignant transformation of GES-1 cells.
A: Cell Counting Kit-8 detection of the proliferative capacity of GES-1 cells following chronic N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) exposure across 30 generations; B: Changes in the clonogenic capacity of MNNG-treated GES-1 cells; C: Alterations in the migratory invasive capacities of MNNG-treated GES-1 cells; D: Protein levels of epithelial-to-mesenchymal transition (EMT), stemness, and proliferative markers; E: mRNA levels of EMT, stemness, and proliferative markers. bP < 0.01. cP < 0.001. dP < 0.0001. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; OD: Optical density.
- Citation: Liang ZF, Xu YM, Song JJ, Gao ZH, Qian H, Xu XZ. Interventional effect of hesperetin on N-methyl-N’-nitro-N-nitrosoguanidine-induced exosomal circ008274 in affecting normal cells to promote gastric carcinogenesis. World J Gastroenterol 2025; 31(16): 104920
- URL: https://www.wjgnet.com/1007-9327/full/v31/i16/104920.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i16.104920